These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8399613)

  • 81. Treatment for peritoneal dialysis-associated peritonitis.
    Ballinger AE; Palmer SC; Wiggins KJ; Craig JC; Johnson DW; Cross NB; Strippoli GF
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD005284. PubMed ID: 24771351
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Peritonitis caused by Mycobacterium kansasii in a patient undergoing continuous ambulatory peritoneal dialysis.
    Giladi M; Lee BE; Berlin OG; Panosian CB
    Am J Kidney Dis; 1992 Jun; 19(6):597-9. PubMed ID: 1595710
    [TBL] [Abstract][Full Text] [Related]  

  • 83. VRE and empirical vancomycin for CAPD peritonitis: use at your own/patient's risk.
    Vas SI
    Perit Dial Int; 1998; 18(1):86-7. PubMed ID: 9527040
    [No Abstract]   [Full Text] [Related]  

  • 84. [Peritoneal dialysis-related infections].
    Lebeaux D; Touam M
    Rev Prat; 2014 May; 64(5):656-7. PubMed ID: 24923051
    [No Abstract]   [Full Text] [Related]  

  • 85. Evaluation of the pharmacodynamic profile of commonly used intravenous vancomycin dosing schemes in patients on automated peritoneal dialysis.
    Cardone KE; Chen WZ; Grabe DW; Batzold A; Manley HJ; Lodise TP
    J Antimicrob Chemother; 2014 Jul; 69(7):1873-6. PubMed ID: 24722842
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Ciprofloxacin in the treatment of gram-positive bacterial peritonitis in patients undergoing CAPD.
    Pérez-Fontán M; Rosales M; Fernández F; Moncalián J; Fernández-Rivera C; Alonso A; Valdés F
    Perit Dial Int; 1991; 11(3):233-6. PubMed ID: 1912018
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Antimicrobial-resistant gram-positive bacteria in PD peritonitis and the newer antibiotics used to treat them.
    Salzer W
    Perit Dial Int; 2005; 25(4):313-9. PubMed ID: 16022084
    [TBL] [Abstract][Full Text] [Related]  

  • 89. CAPD peritonitis after colonoscopy: follow the guidelines.
    Poortvliet W; Selten HP; Raasveld MH; Klemt-Kropp M
    Neth J Med; 2010 Sep; 68(9):377-8. PubMed ID: 20919445
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Peritonitis due to Staphylococcus sciuri in a patient on continuous ambulatory peritoneal dialysis.
    Wallet F; Stuit L; Boulanger E; Roussel-Delvallez M; Dequiedt P; Courcol RJ
    Scand J Infect Dis; 2000; 32(6):697-8. PubMed ID: 11200385
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis.
    Gucek A; Bren AF; Hergouth V; Lindic J
    Adv Perit Dial; 1997; 13():218-20. PubMed ID: 9360685
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Pharmacokinetics of Intraperitoneal Cefalothin and Cefazolin in Patients Being Treated for Peritoneal Dialysis-Associated Peritonitis.
    Roberts DM; Ranganathan D; Wallis SC; Varghese JM; Kark A; Lipman J; Roberts JA
    Perit Dial Int; 2016; 36(4):415-20. PubMed ID: 26764340
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Vancomycin and ceftazidime in the treatment of CAPD peritonitis.
    Beaman M; Solaro L; McGonigle RJ; Michael J; Adu D
    Nephron; 1989; 51(1):51-5. PubMed ID: 2644565
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Intraperitoneal Meropenem for Polymicrobial Peritoneal Dialysis-Related Peritonitis.
    de Fijter CW; Jakulj L; Amiri F; Zandvliet A; Franssen E
    Perit Dial Int; 2016 9-10; 36(5):572-3. PubMed ID: 27659932
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Ciprofloxacin treatment of bacterial peritonitis associated with chronic ambulatory peritoneal dialysis caused by Neisseria cinerea.
    Taegtmeyer M; Saxena R; Corkill JE; Anijeet H; Parry CM
    J Clin Microbiol; 2006 Aug; 44(8):3040-1. PubMed ID: 16891538
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Linezolid for treatment of vancomycin-resistant enterococcal peritonitis.
    Bailey EM; Faber MD; Nafziger DA
    Am J Kidney Dis; 2001 Oct; 38(4):E20. PubMed ID: 11576907
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pharmacokinetics of intraperitoneal piperacillin/tazobactam in patients on peritoneal dialysis with and without pseudomonas peritonitis.
    Zaidenstein R; Weissgarten J; Dishi V; Koren M; Soback S; Gips M; Averbuch Z; Simantov R; Assulin E; Golik A
    Perit Dial Int; 2000; 20(2):227-31. PubMed ID: 10809248
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): diagnostic findings, therapeutic outcome and complications.
    Tranaeus A; Heimbürger O; Lindholm B
    Perit Dial Int; 1989; 9(3):179-90. PubMed ID: 2488363
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A large step in the treatment of peritonitis in peritoneal dialysis patients.
    Vas SI; Keane WF
    Perit Dial Int; 1996; 16(6):548-9. PubMed ID: 8981518
    [No Abstract]   [Full Text] [Related]  

  • 100. Effect of peritoneal dialysis fluid and pH on bactericidal activity of ciprofloxacin.
    McCormick EM; Echols RM
    Antimicrob Agents Chemother; 1987 Apr; 31(4):657-9. PubMed ID: 3606070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.